Home LiteratureArticle Details
PMID: 2195989 Published · ppublish English Journal Article Review

Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Antonie van Leeuwenhoek ·Vol. 58 ·No. 1 ·1990-06-00 ·Pages 1-47

van Dam JE, Fleer A, Snippe H

Abstract

暂无摘要

MeSH Terms
Animals Antibodies, Bacterial/biosynthesis Bacterial Vaccines/immunology Carbohydrate Sequence Cell Wall/immunology Humans Molecular Sequence Data Pneumococcal Infections/prevention & control Pneumococcal Vaccines Polysaccharides, Bacterial/analysis,immunology Streptococcus pneumoniae/immunology,pathogenicity Virulence
Chemicals
Antibodies, Bacterial Bacterial Vaccines Pneumococcal Vaccines Polysaccharides, Bacterial
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
van Dam J E
Eijkman-Winkler Laboratory of Medical Microbiology, Utrecht University, The Netherlands.
Fleer A
Snippe H
References (388)
388 references, click to expand
  1. Effect of culture conditions on the structure of Streptococcus pneumoniae type 19A(57) capsular polysaccharide.
    Infect Immun. 1987 Aug;55(8):1819-23 PMID: 3610316
  2. Synthesis of a trisaccharide component of the capsular polysaccharide of Streptococcus pneumoniae type 19F.
    Carbohydr Res. 1988 Feb 1;172(2):195-207 PMID: 3370647
  3. Vaccines against encapsulated bacteria: a global agenda.
    Rev Infect Dis. 1987 Jan-Feb;9(1):176-88 PMID: 3547570
  4. Increased concentration of serum IgA antibody to pneumococcal polysaccharides in patients with IgA nephropathy.
    Clin Exp Immunol. 1987 Jan;67(1):124-9 PMID: 3497740
  5. Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies, types 3 and 8. I. Isolation of oligosaccharides from acid and from enzymatic hydrolysates of S3 and S8.
    Immunochemistry. 1966 May;3(3):195-212 PMID: 4381030
  6. Effect of human airway lysozyme on the in vitro growth of type I Streptococcus pneumoniae.
    Eur J Respir Dis. 1987 Oct;71(4):295-305 PMID: 3691684
  7. Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3.
    Infect Immun. 1983 Nov;42(2):842-4 PMID: 6642655
  8. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    J Immunol. 1986 Sep 1;137(5):1708-13 PMID: 3091688
  9. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children.
    Lancet. 1986 Oct 18;2(8512):877-81 PMID: 2876325
  10. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
    J Immunol. 1988 Jun 1;140(11):3793-800 PMID: 3372993
  11. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    J Infect Dis. 1985 Oct;152(4):701-9 PMID: 3930618
  12. N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis.
    J Exp Med. 1987 Apr 1;165(4):1207-11 PMID: 2435835
  13. The effect of serial intravenous immunoglobulin infusion on type-specific anti-pneumococcal antibodies in children.
    Acta Pathol Microbiol Immunol Scand C. 1986 Oct;94(5):207-11 PMID: 3565026
  14. Degradation of human immunoglobulins by proteases from Streptococcus pneumoniae obtained from various human sources.
    Infect Immun. 1984 Apr;44(1):33-7 PMID: 6368393
  15. Empyema in pneumococcal bacteremia.
    Rev Infect Dis. 1988 Nov-Dec;10(6):1227-8 PMID: 3206062
  16. Protein serotyping of Streptococcus pneumoniae based on reactivity to six monoclonal antibodies.
    Microb Pathog. 1988 Sep;5(3):159-67 PMID: 3216776
  17. Response of patients with Hodgkin's disease to pneumococcal vaccine.
    Ann Intern Med. 1979 Jun;90(6):887-92 PMID: 36021
  18. Natural killer cell regulation of age-related and type-specific variations in antibody responses to pneumococcal polysaccharides.
    J Exp Med. 1986 Nov 1;164(5):1505-15 PMID: 2430043
  19. Requirements for activation of contrasuppressor T cells by type III pneumococcal polysaccharide.
    J Immunol. 1986 Jan;136(2):396-401 PMID: 2867113
  20. Nature of cross-reactivity between Haemophilus influenzae types a and b and Streptococcus pneumoniae types 6A and 6B.
    Acta Pathol Microbiol Immunol Scand C. 1983 Dec;91(6):371-6 PMID: 6201038
  21. Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies, types 3 and 8. 3. Binding of a labeled oligosaccharide derived from S8 by anti-S8 antibodies.
    J Immunol. 1968 Jun;100(6):1237-44 PMID: 4387095
  22. The specific substance from Pneumococcus type 34 (41). The phosphodiester linkages.
    Biochem J. 1968 Oct;109(4):597-602 PMID: 4386682
  23. Structural studies of the Klebsiella type 47 capsular polysaccharide.
    Carbohydr Res. 1973 Apr;27(2):373-8 PMID: 4724213
  24. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.
    Infect Immun. 1986 May;52(2):519-28 PMID: 3516876
  25. Impaired pulmonary clearance of pneumococci in neonatal rats.
    Pediatr Res. 1987 Dec;22(6):736-42 PMID: 3431960
  26. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae types 15B and 15C.
    Carbohydr Res. 1987 Apr 15;162(1):111-6 PMID: 3594475
  27. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention.
    Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S1-17 PMID: 7025155
  28. Lectin-induced modulation of the antibody response to type III pneumococcal polysaccharide.
    Cell Immunol. 1984 Jan;83(1):26-33 PMID: 6692477
  29. The in vivo behavior of granulocytes labeled with indium-111 in a canine model of pneumococcal pneumonia.
    Am Rev Respir Dis. 1984 Apr;129(4):602-6 PMID: 6712001
  30. Immunochemical studies on blood groups. XXIX. Action of various oligosaccharides from human milk in inhibiting the cross-reactions of type XIV antipneumococcal sera with partially hydrolyzed blood group substances (P1 fractions).
    Arch Biochem Biophys. 1962 Sep;Suppl 1:181-6 PMID: 14030028
  31. Pneumococcal vaccine: a tool for the evaluation of the B-cell function of the immune system.
    Proc Soc Exp Biol Med. 1983 Dec;174(3):309-15 PMID: 6364146
  32. The induction of meningeal inflammation by components of the pneumococcal cell wall.
    J Infect Dis. 1985 May;151(5):859-68 PMID: 3989321
  33. Characterization of the binding of and the immune response to pneumococcal group 9 capsular polysaccharides.
    Mol Immunol. 1987 May;24(5):427-33 PMID: 3657788
  34. Regulation of idiotope expression. I. The effect of antigen dose on expression of certain T15 idiotopes during primary IgM response to S. pneumoniae R36a.
    J Immunol. 1985 Mar;134(3):1926-9 PMID: 3881527
  35. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae.
    J Immunol. 1982 Jun;128(6):2493-6 PMID: 7077077
  36. Impaired antipneumococcal antibody production in patients without spleens.
    Br Med J (Clin Res Ed). 1985 Jan 5;290(6461):14-6 PMID: 3917317
  37. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
    Infect Immun. 1977 Nov;18(2):291-7 PMID: 21849
  38. Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine.
    N Engl J Med. 1986 Aug 21;315(8):499-503 PMID: 3488503
  39. Specific antibodies to diphtheria toxin and type 6A pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen.
    Mol Immunol. 1985 Aug;22(8):907-19 PMID: 4047043
  40. The pneumococcal polysaccharide S4: a structural re-assessment.
    Carbohydr Res. 1988 Dec 31;184:279-84 PMID: 3242813
  41. Natural and vaccine-related immunity to Streptococcus pneumoniae.
    J Infect Dis. 1986 Aug;154(2):245-56 PMID: 3722865
  42. Maternal-fetal transfer of pneumococcal capsular polysaccharide antibodies.
    Am J Dis Child. 1985 Apr;139(4):378-80 PMID: 3976628
  43. Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharide-protein vaccines.
    Infect Immun. 1988 May;56(5):1391-3 PMID: 3356469
  44. Nonionic block polymer surfactants enhance the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 in normal and Xid mice.
    J Immunol. 1989 Nov 1;143(9):3049-53 PMID: 2809215
  45. Effects of pneumococcal vaccination on tonsillo-pharyngitis and upper respiratory tract flora.
    Int Arch Allergy Appl Immunol. 1985;78(2):161-6 PMID: 3899947
  46. Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens.
    Infect Immun. 1987 Jun;55(6):1375-80 PMID: 3570469
  47. Antibody response to pneumococcal vaccination in patients with myelomatosis.
    Scand J Haematol. 1983 Apr;30(4):324-30 PMID: 6857148
  48. Degradation of a pneumococcal type-specific polysaccharide with exposure of group-specificity.
    Proc Natl Acad Sci U S A. 1970 Sep;67(1):138-42 PMID: 4394061
  49. Immunochemical relationships of certain capsular polysaccharides of Klebsiella, pneumococci and Rhizobia.
    J Immunol. 1970 Jun;104(6):1321-8 PMID: 4192572
  50. Immune response after splenectomy.
    Lancet. 1978 Jan 28;1(8057):178-81 PMID: 74605
  51. Activation of human complement by the pneumococcal toxin pneumolysin.
    Infect Immun. 1984 Mar;43(3):1085-7 PMID: 6698602
  52. Pneumococcal vaccine and otitis media.
    Lancet. 1980 Sep 13;2(8194):547-51 PMID: 6106735
  53. Defective binding of the third component of complement (C3) to Streptococcus pneumoniae in multiple myeloma.
    Blood. 1984 Apr;63(4):949-57 PMID: 6231069
  54. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 5.
    Carbohydr Res. 1985 Jul 1;140(1):101-10 PMID: 4053092
  55. Regulation of IgG responses by helper and suppressor T cells activated by pneumococcal capsular polysaccharides.
    Cell Immunol. 1989 Mar;119(1):222-32 PMID: 2465833
  56. THE COMBINING REGIONS OF THE TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND HOMOLOGOUS ANTIBODY.
    Biochemistry. 1963 Nov-Dec;2:1278-88 PMID: 14093902
  57. BREAKING OF IMMUNOLOGICAL PARALYSIS BY INJECTION OF A SPECIFIC DEPOLYMERASE.
    Nature. 1964 Dec 26;204:1319-20 PMID: 14254431
  58. Pneumococcal vaccine immunization of patients with renal impairment.
    Proc Soc Exp Biol Med. 1986 Sep;182(4):468-73 PMID: 3526355
  59. Opsonic requirements for hepatic clearance of pneumococci.
    Infect Immun. 1986 May;52(2):499-503 PMID: 3699895
  60. Structural determination of the capsular polysaccharide of Streptococcus pneumoniae type 18C (56).
    Carbohydr Res. 1984 Aug 1;131(1):119-29 PMID: 6488199
  61. Streptococcus pneumoniae resistant to penicillin and chloramphenicol.
    Lancet. 1977 Nov 12;2(8046):995-7 PMID: 72950
  62. Fatal post-splenectomy pneumococcal sepsis despite prophylaxis.
    Lancet. 1984 Sep 22;2(8404):694-5 PMID: 6147714
  63. Conformation of crystalline type III pneumococcal polysaccharide.
    Carbohydr Res. 1980 Aug 15;83(2):287-302 PMID: 7407799
  64. PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.
    Ann Intern Med. 1964 May;60:759-76 PMID: 14156606
  65. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide. II. Ability of suppressor T cells to act on both B cells and amplified T cells to limit the magnitude of the antibody response.
    J Immunol. 1977 Sep;119(3):1163-8 PMID: 19533
  66. The specific capsular polysaccharide of Streptococcus pneumoniae type 33F.
    Can J Biochem Cell Biol. 1984 Aug;62(8):666-77 PMID: 6093964
  67. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
    N Engl J Med. 1987 Sep 17;317(12):717-22 PMID: 3306379
  68. Development of anti-polysaccharide antibodies in asplenic children.
    Clin Exp Immunol. 1986 Nov;66(2):457-62 PMID: 3815900
  69. Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life.
    Am J Epidemiol. 1982 Oct;116(4):692-703 PMID: 7137156
  70. A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid.
    Microb Pathog. 1987 Oct;3(4):249-60 PMID: 2462151
  71. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
    Infect Immun. 1983 Jun;40(3):856-61 PMID: 6852923
  72. A sandwich adhesion on Streptococcus pneumoniae attaching to human oropharyngeal epithelial cells in vitro.
    Microb Pathog. 1988 Apr;4(4):267-78 PMID: 2849030
  73. Regulation of the antibody response to type III pneumococcal polysaccharide by contrasuppressor T cells.
    J Exp Med. 1984 Jul 1;160(1):42-54 PMID: 6234375
  74. The type-specific substance from Pneumococcus type 11A(43).
    Biochem J. 1969 Oct;115(1):37-45 PMID: 4390773
  75. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream.
    Rev Infect Dis. 1983 Sep-Oct;5 Suppl 4:S797-805 PMID: 6356294
  76. Genetic control of the antibody response to type III pneumococcal polysaccharide in mice. III. Analysis of genes governing the expression of regulatory T cell activity.
    J Immunogenet. 1976 Aug;3(4):275-86 PMID: 10335
  77. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.
    J Exp Med. 1978 Sep 1;148(3):776-86 PMID: 29937
  78. The specific capsular polysaccharide of Streptococcus pneumoniae type 9V.
    Can J Biochem. 1981 Jul;59(7):524-33 PMID: 6271367
  79. Continuing controversy: pneumococcal vaccine and COPD.
    Chest. 1987 Aug;92(2):193-4 PMID: 3608587
  80. Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharide.
    Infect Immun. 1989 Mar;57(3):912-7 PMID: 2783922
  81. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis.
    Rev Infect Dis. 1985 Mar-Apr;7(2):133-42 PMID: 3890093
  82. Hydrolytic stability of pneumococcal group 6 (type 6A and 6B) capsular polysaccharides.
    Infect Immun. 1982 Jul;37(1):89-103 PMID: 7107011
  83. Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics.
    JAMA. 1980 Dec 12;244(23):2621-4 PMID: 7431608
  84. Precipitating cross-reactions among pneumococcal types.
    Infect Immun. 1983 Sep;41(3):1234-44 PMID: 6885161
  85. T-cell recognition of antigen and the Ia molecule as a ternary complex.
    Nature. 1986 Mar 13-19;320(6058):176-9 PMID: 3005880
  86. Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment.
    J Gerontol. 1987 May;42(3):265-70 PMID: 3571861
  87. Subclass of individual IgA-secreting human lymphocytes. Investigation of in vivo pneumococcal polysaccharide-induced and in vitro mitogen-induced blood B cells by monolayer plaque-forming cell assays.
    J Immunol. 1988 Mar 1;140(5):1496-9 PMID: 2831268
  88. [Pneumococcal vaccination of the pregnant woman in Africa and passive immunity of the child. Immunologic control by the ELISA method].
    Pathol Biol (Paris). 1985 Sep;33(7):764-7 PMID: 3909074
  89. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974.
    J Clin Microbiol. 1977 Feb;5(2):154-66 PMID: 14971
  90. Opsonin-independent phagocytosis of surface-adherent bacteria by human alveolar macrophages.
    J Leukoc Biol. 1984 Dec;36(6):689-701 PMID: 6438262
  91. Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide.
    J Exp Med. 1983 Sep 1;158(3):703-17 PMID: 6193230
  92. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.
    Infect Immun. 1982 Apr;36(1):184-8 PMID: 7076292
  93. Maternal immunization and the immune response of neonates to pneumococcal polysaccharides.
    Rev Infect Dis. 1987 May-Jun;9(3):494-510 PMID: 2955505
  94. THE DIFFERENTIATION OF SEROTYPE A AND B DEXTRANS BY MEANS OF PARTIAL ACETOLYSIS.
    Arch Biochem Biophys. 1964 Feb;104:305-13 PMID: 14163897
  95. Immunochemical studies on cross-reactions of antipneumococcal sera. II. Cross-reactions of types IX and XII antipneumococcal sera with dextrans.
    J Immunol. 1960 Apr;84:347-57 PMID: 13851076
  96. Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria.
    Infect Immun. 1988 Mar;56(3):539-47 PMID: 2893771
  97. Contribution of autolysin to virulence of Streptococcus pneumoniae.
    Infect Immun. 1989 Aug;57(8):2324-30 PMID: 2568343
  98. Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease.
    Blood. 1979 Nov;54(5):1171-5 PMID: 40635
  99. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 18A.
    Carbohydr Res. 1988 Mar 1;173(2):227-33 PMID: 3359454
  100. Lipoteichoic acid: a specific inhibitor of autolysin activity in Pneumococcus.
    Proc Natl Acad Sci U S A. 1975 May;72(5):1690-4 PMID: 239401
  101. Pneumococcal vaccine: clinical efficacy and effectiveness.
    Ann Intern Med. 1982 Feb;96(2):208-20 PMID: 6800290
  102. Pneumococcal disease in a medium-sized community in the United States.
    JAMA. 1982 Sep 24;248(12):1486-9 PMID: 7109171
  103. Impaired humoral immunity in treated Hodgkin's disease.
    N Engl J Med. 1977 Aug 4;297(5):245-8 PMID: 301608
  104. Induction of increased antibody responses to pneumococcal type 19F polysaccharide by Klebsiella polysaccharide.
    J Infect Dis. 1985 Apr;151(4):658-64 PMID: 3973415
  105. The type-specific substance from Pneumococcus type 33B.
    Biochem J. 1974 Mar;137(3):603-6 PMID: 4154055
  106. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus.
    J Rheumatol. 1984 Jun;11(3):306-8 PMID: 6737372
  107. DECOMPOSITION OF THE CAPSULAR POLYSACCHARIDE OF PNEUMOCOCCUS TYPE III BY A BACTERIAL ENZYME.
    J Exp Med. 1931 Jun 30;54(1):51-71 PMID: 19869902
  108. The role of a functionally distinct IgM anti-type III pneumococcal polysaccharide (SIII) in low-dose paralysis to SIII in mice.
    Aust J Exp Biol Med Sci. 1986 Feb;64 ( Pt 1):19-35 PMID: 2938567
  109. Isomeric, anti-rhamnose antibodies having specificity for rhamnose-containing, streptococcal heteroglycans.
    Carbohydr Res. 1983 Dec 23;124(2):253-63 PMID: 6423281
  110. Capsulation of pneumococcus with soluble cell wall-like polysaccharide. II. Nonidentity of cell wall and soluble cell wall-like polysaccharides derived from the same and from different pneumococcal strains.
    J Exp Med. 1971 Sep 1;134(3 Pt 1):600-17 PMID: 15776564
  111. A longitudinal study of the nasopharyngeal carriage of pneumococci as related to pneumococcal vaccination in children attending day-care centres.
    Acta Otolaryngol. 1984 Nov-Dec;98(5-6):524-32 PMID: 6524348
  112. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    J Immunol. 1983 Feb;130(2):845-9 PMID: 6848598
  113. Quantitation of blood lymphocytes secreting antibodies to pneumococcal polysaccharides after in vivo antigenic stimulation.
    Scand J Immunol. 1986 Feb;23(2):189-94 PMID: 3513298
  114. Response to pneumococcal vaccine among children with Hodgkin's disease.
    Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S133-43 PMID: 6895119
  115. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study.
    N Engl J Med. 1986 Nov 20;315(21):1318-27 PMID: 3534568
  116. Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells.
    Rev Infect Dis. 1981 Mar-Apr;3(2):332-41 PMID: 6973183
  117. Bacteremic pneumococcal pneumonia in the elderly.
    Am J Med Sci. 1984 Oct;288(3):114-8 PMID: 6486161
  118. Changes in intrinsic circular dichroism of several homogeneous anti-type 3 pneumococcal antibodies on binding of a small hapten.
    Proc Natl Acad Sci U S A. 1972 Nov;69(11):3399-403 PMID: 4404497
  119. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine.
    Arch Intern Med. 1986 Aug;146(8):1554-6 PMID: 3524494
  120. Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients.
    J Lab Clin Med. 1980 Aug;96(2):363-70 PMID: 7400669
  121. Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection.
    J Clin Microbiol. 1986 Jan;23(1):56-61 PMID: 3700607
  122. Pneumococcal antibodies and complement during and after periods of recurrent otitis.
    Int J Pediatr Otorhinolaryngol. 1984 Mar;7(1):39-49 PMID: 6724809
  123. The specific capsular polysaccharide of Streptococcus pneumoniae type 20.
    Can J Biochem Cell Biol. 1983 Apr;61(4):178-90 PMID: 6850414
  124. Immune response to pneumococcal vaccine in mothers to infants with group B streptococcal septicemia: evidence for a divergent IgG/IgM ratio.
    Int Arch Allergy Appl Immunol. 1985;76(4):369-72 PMID: 3884518
  125. Specific capsular polysaccharide of type 46 Streptococcus pneumoniae (American type 73).
    Infect Immun. 1981 Jun;32(3):1024-7 PMID: 7251155
  126. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.
    Infect Immun. 1989 Jul;57(7):2037-42 PMID: 2731982
  127. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
    Clin Exp Immunol. 1986 Jan;63(1):127-34 PMID: 3955880
  128. Estimation of the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 by inhibition ELISA.
    Mol Immunol. 1989 Mar;26(3):269-74 PMID: 2704374
  129. Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.
    Infect Immun. 1983 Feb;39(2):993-9 PMID: 6832828
  130. Regulatory role of T cells in IgG antibody formation and immune memory to type III Pneumococcal polysaccharide.
    J Immunol. 1974 Dec;113(6):1909-20 PMID: 4154347
  131. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    J Immunol. 1984 Aug;133(2):882-5 PMID: 6234363
  132. Pneumococcal antibodies of different immunoglobulin subclasses in normal and IgG subclass deficient individuals of various ages.
    Acta Otolaryngol. 1986 Jan-Feb;101(1-2):146-51 PMID: 3962646
  133. Pneumococcal vaccine improves pulmonary clearance of live pneumococci after splenectomy.
    J Surg Res. 1989 Oct;47(4):283-7 PMID: 2770287
  134. Production of soluble suppressor factor by spleen cells from mice immunized with type III pneumococcal polysaccharide.
    J Immunol. 1985 Oct;135(4):2551-6 PMID: 2411801
  135. IgA-driven antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes.
    Am Rev Respir Dis. 1988 Jan;137(1):138-43 PMID: 3337454
  136. Prevention by a platelet-derived factor (platelet factor 4) of induction of low dose tolerance to pneumococcal polysaccharides.
    Cell Immunol. 1988 Sep;115(2):221-7 PMID: 3409328
  137. ELISA determination of IgG antibodies to pneumococcal capsular polysaccharides in a group of children.
    J Immunol Methods. 1987 Nov 23;104(1-2):143-8 PMID: 3680953
  138. Vaccination-induced circulation of human B cells secreting type-specific antibodies against pneumococcal polysaccharides.
    Scand J Immunol. 1987 Jan;25(1):61-7 PMID: 3492757
  139. Polyvalent pneumococcal immunization of patients with plasma cell dyscrasias.
    Cancer. 1981 Sep 15;48(6):1377-80 PMID: 7023655
  140. Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates.
    Infect Immun. 1988 Sep;56(9):2292-8 PMID: 3410538
  141. Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae.
    Lancet. 1986 Aug 2;2(8501):284-5 PMID: 2874307
  142. IgG and IgM pneumococcal polysaccharide antibody responses in infants.
    Pediatr Res. 1984 Nov;18(11):1067-71 PMID: 6514433
  143. Comparison of antibody levels and protective efficacy against pneumococci in two immunoglobulin preparations for intravenous use.
    Int Arch Allergy Appl Immunol. 1986;80(3):307-11 PMID: 3087886
  144. Structural studies of the capsular antigen from Streptococcus pneumoniae type 26.
    Carbohydr Res. 1979 Aug;73:175-82 PMID: 38908
  145. The composition of pneumococcus type-specific substances containing phosphorus.
    Biochim Biophys Acta. 1962 Feb 12;57:146-8 PMID: 13911086
  146. Enhanced IgG1 and IgG3 responses to pneumococcal polysaccharides in isolated IgA deficiency.
    Clin Exp Immunol. 1989 Feb;75(2):201-5 PMID: 2702775
  147. Immunochemistry of the pneumococcal types II. V. and VI. I. The relation of Type VI to Type II and other correlations between chemical constitution and precipitation in antisera to type VI.
    J Bacteriol. 1960 Aug;80:145-53 PMID: 14400599
  148. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 1.
    Carbohydr Res. 1980 Jan 1;78(1):111-7 PMID: 7351025
  149. Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae.
    Nature. 1981 Nov 5;294(5836):88-90 PMID: 6170000
  150. Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.
    J Immunol. 1974 Jan;112(1):404-9 PMID: 4149590
  151. Induction of regulatory T-lymphocyte responses by liposomes carrying major histocompatibility complex molecules and foreign antigen.
    Nature. 1985 May 23-29;315(6017):327-9 PMID: 3873617
  152. Peptidoglycan cross-linking and teichoic acid attachment in Streptococcus pneumoniae.
    J Bacteriol. 1985 Jul;163(1):46-54 PMID: 4008447
  153. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates.
    Infect Immun. 1982 Jul;37(1):15-22 PMID: 6809623
  154. Effect of underlying disease and age on pneumococcal serotype distribution.
    Am J Med. 1983 Aug;75(2):199-205 PMID: 6881171
  155. The type-specific substance from Pneumococcus type 10A(34). Structure of the dephosphorylated repeating unit.
    Biochem J. 1966 Sep;100(3):801-10 PMID: 4381845
  156. Prevention of pneumococcal bacteremia by immunization with type 6 pneumococcal capsular polysaccharide vaccine in splenectomized rats.
    J Infect Dis. 1989 Jul;160(1):66-75 PMID: 2732517
  157. Isolation and characterization of circulating immune complexes from patients with pneumococcal pneumonia.
    Infect Immun. 1987 Aug;55(8):1737-42 PMID: 3610313
  158. Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides.
    J Pediatr. 1984 Oct;105(4):576-82 PMID: 6481533
  159. Pneumococcal polysaccharides induce antibody formation by human B lymphocytes in vitro.
    J Immunol. 1985 Jul;135(1):1-4 PMID: 3889152
  160. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus.
    Am Rev Respir Dis. 1986 Nov;134(5):1040-4 PMID: 3777666
  161. Pneumococcal Forssman antigen: enrichment in mesosomal membranes and specific binding to the autolytic enzyme of Streptococcus pneumoniae.
    J Bacteriol. 1985 Jan;161(1):18-24 PMID: 2857159
  162. Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia.
    J Pediatr. 1984 Aug;105(2):261-3 PMID: 6747758
  163. Binding of immunogenic peptides to Ia histocompatibility molecules.
    Nature. 1985 Sep 26-Oct 2;317(6035):359-61 PMID: 3876513
  164. Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.
    Infect Immun. 1985 Oct;50(1):213-7 PMID: 4044034
  165. The specific capsular polysaccharide of Streptococcus pneumoniae type 15F.
    Mol Immunol. 1982 Feb;19(2):235-46 PMID: 7099164
  166. Reactivity and antibody responses of volunteers given two or three doses of pneumococcal vaccine.
    Proc Soc Exp Biol Med. 1984 Nov;177(2):220-5 PMID: 6483857
  167. Phosphorylcholine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody.
    Infect Immun. 1984 Mar;43(3):876-8 PMID: 6199306
  168. Regulation of the antibody response to type 3 pneumococcal polysaccharide. 3. Role of regulatory T cells in the development of an IgG and IgA antibody response.
    J Immunol. 1974 Mar;112(3):1042-50 PMID: 4149561
  169. Opsonic requirements for intravascular clearance after splenectomy.
    N Engl J Med. 1981 Jan 29;304(5):245-50 PMID: 7442756
  170. Antibody response to pneumococcal vaccine in splenectomized children.
    Acta Pathol Microbiol Immunol Scand C. 1983 Apr;91(2):169-80 PMID: 6880749
  171. Isolation and characterization of a new endo-beta-galactosidase from Diplococcus pneumoniae.
    Biochemistry. 1985 Apr 23;24(9):2154-63 PMID: 3922410
  172. IgG subclasses and antibodies to group B streptococci, pneumococci, and tetanus toxoid in preterm neonates after intravenous infusion of immunoglobulin to the mothers.
    Pediatr Res. 1986 Oct;20(10):933-6 PMID: 3534781
  173. T-cell-mediated association of peptide antigen and major histocompatibility complex protein detected by energy transfer in an evanescent wave-field.
    Nature. 1986 Mar 13-19;320(6058):179-81 PMID: 2936964
  174. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
    J Immunol. 1978 Jan;120(1):174-8 PMID: 24071
  175. THE SPECIFIC POLYSACCHARIDE OF TYPE XVIII PNEUMOCOCCUS. III.
    Biochemistry. 1963 Nov-Dec;2:1288-94 PMID: 14093903
  176. Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates.
    Infect Immun. 1989 Sep;57(9):2712-8 PMID: 2759707
  177. Comparative role of complement in pneumococcal and staphylococcal pneumonia.
    Infect Immun. 1982 Sep;37(3):1270-7 PMID: 6982230
  178. Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine.
    J Clin Microbiol. 1983 Nov;18(5):1102-7 PMID: 6643664
  179. Immunosuppressive effect of pneumococcal vaccine contaminated with blood-group-A-like substance.
    Lancet. 1988 Apr 2;1(8588):771 PMID: 2895302
  180. Pneumococcal cell wall phosphorylcholine elicits polyclonal antibody secretion in mice.
    Eur J Immunol. 1984 Jul;14(7):589-94 PMID: 6745313
  181. [Synthesis of trisaccharide units from capsular polysaccharides of Streptococcus pneumoniae].
    Carbohydr Res. 1988 Aug 15;179:173-97 PMID: 3208246
  182. The structure of the serotype 2 capsular polysaccharide of Aerobacter aerogenes.
    Biochemistry. 1967 Sep;6(9):2755-67 PMID: 4293395
  183. Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway.
    Mol Immunol. 1983 Nov;20(11):1201-7 PMID: 6558418
  184. Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease.
    Ann Intern Med. 1986 Apr;104(4):467-75 PMID: 3082268
  185. Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues.
    J Exp Med. 1985 Aug 1;162(2):573-82 PMID: 2410529
  186. Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme.
    J Biol Chem. 1970 Jan 25;245(2):287-98 PMID: 4391619
  187. Epidemiological studies of Streptococcus pneumoniae in infants: antibody to types 3, 6, 14, and 23 in the first two years of life.
    J Infect Dis. 1988 Nov;158(5):948-55 PMID: 3183428
  188. Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers.
    Infect Immun. 1982 Mar;35(3):777-82 PMID: 7068216
  189. The immune response to pneumococcal polysaccharide type III is followed by increased production of an antibody antifactor.
    Scand J Immunol. 1986 Mar;23(3):309-18 PMID: 3513300
  190. Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3.
    J Lab Clin Med. 1988 Oct;112(4):487-97 PMID: 3171357
  191. Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers.
    Infect Immun. 1981 Apr;32(1):311-7 PMID: 7216490
  192. Recurrent idiotopes and internal images.
    EMBO J. 1982;1(2):243-7 PMID: 6985352
  193. Structural determination of the capsular polysaccharide of Streptococcus pneumoniae type 19A (57).
    Carbohydr Res. 1983 Dec 23;124(2):235-45 PMID: 6671199
  194. Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci.
    Infect Immun. 1986 Nov;54(2):448-55 PMID: 3095243
  195. Activation of distinct subsets of T suppressor cells with type III pneumococcal polysaccharide coupled to syngeneic spleen cells.
    Ann N Y Acad Sci. 1982;392:156-66 PMID: 6215877
  196. C1q binding and complement activation by capsular and cell wall components of S. pneumoniae type XIX.
    Acta Pathol Microbiol Scand C. 1981 Dec;89(6):359-64 PMID: 6278825
  197. Pneumococcal carriage and type-specific antibody. Failure of a 14-valent vaccine to reduce carriage in healthy children.
    Am J Dis Child. 1986 Nov;140(11):1183-5 PMID: 3532763
  198. Classical and alternative complement pathway activation by pneumococci.
    Infect Immun. 1977 Aug;17(2):296-302 PMID: 19357
  199. Immunochemical relationships between bacteria belonging to two separate families: pneumococci and Klebsiella.
    Immunochemistry. 1976 Jan;13(1):67-80 PMID: 3470
  200. Immunochemical characterization of cross-reactivity of pneumococcal group 9 capsular polysaccharide types 9N, 9A, 9L, and 9V.
    Infect Immun. 1981 Jan;31(1):371-9 PMID: 7216451
  201. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    J Immunol. 1984 Sep;133(3):1424-30 PMID: 6747291
  202. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.
    Infect Immun. 1984 Jul;45(1):248-54 PMID: 6429048
  203. Application of high-resolution n.m.r. spectroscopy to the elucidation of the structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 7F.
    Carbohydr Res. 1988 Oct 15;182(1):79-99 PMID: 3149544
  204. Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.
    Infect Immun. 1986 Dec;54(3):876-81 PMID: 3781629
  205. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1.
    J Infect Dis. 1988 Nov;158(5):983-90 PMID: 3183430
  206. The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection.
    Clin Exp Immunol. 1983 Nov;54(2):319-26 PMID: 6652963
  207. Structural analysis of the specific polysaccharide of Streptococcus pneumoniae type 9L (American type 49).
    Can J Biochem Cell Biol. 1984 Dec;62(12):1309-20 PMID: 6529704
  208. In vivo and in vitro humoral immunity in surgical patients: antibody response to pneumococcal polysaccharide.
    Surgery. 1986 Aug;100(2):229-38 PMID: 3488597
  209. Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA.
    Clin Exp Immunol. 1986 Aug;65(2):427-33 PMID: 3791703
  210. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.
    J Biol Chem. 1987 Jun 15;262(17):8262-7 PMID: 3298228
  211. Role of the spleen in pneumococcal infection.
    Lymphology. 1983 Jun;16(2):115-20 PMID: 6887969
  212. Two synthetic antigens related to Streptococcus pneumoniae type 3 capsular polysaccharide.
    Carbohydr Res. 1985 Sep 1;141(2):199-212 PMID: 4064025
  213. Type-14 pneumococcal vaccine for prevention of gonorrhoea.
    Lancet. 1979 May 12;1(8124):1037 PMID: 86759
  214. Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes.
    J Infect Dis. 1986 Oct;154(4):619-26 PMID: 2943825
  215. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 18F.
    Carbohydr Res. 1988 Mar 1;173(2):217-25 PMID: 3359453
  216. Lack of a requirement for the Fc region of IgG in restoring pneumococcal opsonization via the alternative complement pathway in sickle cell disease.
    J Infect Dis. 1986 Nov;154(5):760-9 PMID: 3095435
  217. Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1.
    Biochemistry. 1980 Sep 30;19(20):4712-9 PMID: 7426624
  218. Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine.
    Proc Soc Exp Biol Med. 1983 Jun;173(2):270-5 PMID: 6867005
  219. Regulation of immunity and tolerance to type III pneumococcal polysaccharide (SIII) by functionally distinct IgM anti-SIII antibodies.
    Aust J Exp Biol Med Sci. 1985 Feb;63 ( Pt 1):19-32 PMID: 4015548
  220. Binding of murine IgM and monoclonal IgM/A (k) hybrid anti-type III pneumococcal polysaccharide (SIII) antibodies to staphylococcal protein A.
    Aust J Exp Biol Med Sci. 1983 Feb;61(Pt 1):91-104 PMID: 6347157
  221. Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin.
    J Clin Microbiol. 1988 Apr;26(4):755-9 PMID: 3366870
  222. Interaction of the pneumococcal amidase with lipoteichoic acid and choline.
    Eur J Biochem. 1985 Jan 15;146(2):417-27 PMID: 3967665
  223. Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future.
    Immunochemistry. 1978 Nov;15(10-11):839-54 PMID: 372096
  224. Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide.
    J Exp Med. 1989 Jun 1;169(6):2121-31 PMID: 2471773
  225. Surface components of Streptococcus pneumoniae.
    Rev Infect Dis. 1981 Mar-Apr;3(2):190-211 PMID: 7256084
  226. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure.
    Am Rev Respir Dis. 1984 Dec;130(6):1174-6 PMID: 6508012
  227. Complement and the host's defense against the pneumococcus.
    Crit Rev Microbiol. 1984;11(3):187-208 PMID: 6391822
  228. Choline-containing bacteriophage receptors in Streptococcus pneumoniae.
    J Bacteriol. 1982 Sep;151(3):1581-90 PMID: 7107560
  229. Detection of antibodies to pneumococcal capsular polysaccharides by enzyme-linked immunosorbent assay.
    J Clin Microbiol. 1982 Mar;15(3):372-8 PMID: 7042742
  230. Association of bacterial carbohydrate-specific cold agglutinin antibody production with immunization by group C, group B type III, and Streptococcus pneumoniae type XIV streptococcal vaccines.
    Infect Immun. 1983 Jul;41(1):205-13 PMID: 6345390
  231. [Pneumococcal capsular types of clinical specimens. Lyon: 1972-1977 and 1978 (author's transl)].
    Pathol Biol (Paris). 1979 Nov;27(9):567-70 PMID: 44740
  232. Pneumococcal polysaccharide conformations.
    Biopolymers. 1981 Dec;20(12):2691-4 PMID: 7326362
  233. Pneumococcal sonicate-induced biphasic granulocytopenia and its dissociation from pulmonary leukostasis. The contribution of pneumococcal products and complement to early and late granulocytopenic phases.
    J Lab Clin Med. 1983 Dec;102(6):987-99 PMID: 6644159
  234. Augmented anti-S 3 antibody responses to an S 3 -protein conjugate.
    J Immunol. 1971 Sep;107(3):685-8 PMID: 4105931
  235. Immune response of neonates to pneumococcal polysaccharide-protein conjugate.
    Immunology. 1982 Jun;46(2):333-42 PMID: 7200956
  236. Pneumococcal antibody levels one decade after immunization of healthy adults.
    Am J Med Sci. 1987 May;293(5):279-84 PMID: 3591818
  237. Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.
    Infect Immun. 1989 Apr;57(4):1078-83 PMID: 2925240
  238. A pneumococcal surface protein (PspB) that exhibits the same protease sensitivity as streptococcal R antigen.
    Infect Immun. 1988 Nov;56(11):3001-3 PMID: 3139568
  239. Study of the mode of action of ribosomal vaccines from Klebsiella and Streptococcus pneumoniae and their ribonucleic and protein fractions using passive immunization.
    Microbiol Immunol. 1982;26(10):933-40 PMID: 6186896
  240. From clonal selection to immune networks: induction of silent idiotypes.
    Ann N Y Acad Sci. 1983;418:1-8 PMID: 6424529
  241. Prevention of pneumococcal infection in children with homozygous sickle cell disease.
    Br Med J (Clin Res Ed). 1984 May 26;288(6430):1567-70 PMID: 6426646
  242. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide.
    Proc Soc Exp Biol Med. 1971 Feb;136(2):612-4 PMID: 4395924
  243. Antibody responses against pneumococcal polysaccharide antigens in vaccinated persons.
    Ann Clin Res. 1982 Dec;14(5-6):267-71 PMID: 7171234
  244. The in vitro B-cell response to pneumococcal polysaccharides in adults and neonates.
    Scand J Immunol. 1987 May;25(5):447-52 PMID: 3495866
  245. Adverse reactions to polyvalent pneumococcal vaccine.
    Scand J Infect Dis. 1982;14(1):67-71 PMID: 7071529
  246. STUDIES ON ANTIBACTERIAL IMMUNITY INDUCED BY ARTIFICIAL ANTIGENS : I. IMMUNITY TO EXPERIMENTAL PNEUMOCOCCAL INFECTION WITH AN ANTIGEN CONTAINING CELLOBIURONIC ACID.
    J Exp Med. 1939 Feb 28;69(3):353-64 PMID: 19870851
  247. Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.
    Infect Immun. 1983 Apr;40(1):219-24 PMID: 6403465
  248. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production.
    J Infect Dis. 1986 Apr;153(4):682-93 PMID: 3950449
  249. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.
    J Clin Invest. 1987 Feb;79(2):388-98 PMID: 3805275
  250. Antibody response to pneumococcal vaccine in children aged 5 to 15 years.
    Am J Dis Child. 1986 Feb;140(2):135-8 PMID: 3946323
  251. Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine.
    Lancet. 1981 Apr 11;1(8224):804-7 PMID: 6111673
  252. The specific capsular polysaccharide of Streptococcus pneumoniae type 15A (American type 30).
    Can J Biochem Cell Biol. 1984 Apr;62(4):151-61 PMID: 6426760
  253. Antibody response to pneumococcal vaccination in children younger than five years of age.
    J Infect Dis. 1983 Jul;148(1):131-7 PMID: 6886479
  254. World-wide development of antibiotic resistance in pneumococci.
    Eur J Clin Microbiol. 1987 Aug;6(4):367-77 PMID: 3311732
  255. IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies.
    J Immunol. 1980 Jun;124(6):2596-600 PMID: 6768797
  256. IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms.
    J Immunol. 1983 Jun;130(6):2882-5 PMID: 6854021
  257. Structural studies on the specific type-14 pneumococcal polysaccharide.
    Carbohydr Res. 1977 Sep;58(1):177-86 PMID: 21030
  258. STUDIES ON THE PRECIPITIN REACTION : PRECIPITATING HAPTENS; SPECIES DIFFERENCES IN ANTIBODIES.
    J Exp Med. 1933 Feb 28;57(3):373-9 PMID: 19870136
  259. The type-specific substance from Pneumococcus type 13.
    Biochem J. 1972 Nov;130(1):45-54 PMID: 4144077
  260. Some aspects of the pneumococcal carrier state.
    J Antimicrob Chemother. 1986 Jul;18 Suppl A:35-45 PMID: 3745031
  261. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.
    Infect Immun. 1982 Mar;35(3):800-8 PMID: 6802760
  262. Identification of D-galacturonic acid in the specific capsular polysaccharide of pneumococcal type XXV.
    Carbohydr Res. 1976 Jun;48(2):304-5 PMID: 7354
  263. On the phosphate linkages and the structure of a disaccharide unit of the type-specific polysaccharide of Pneumococcus type XIX.
    Carbohydr Res. 1979 Oct;75:191-8 PMID: 39675
  264. Induction of meningeal inflammation by diverse bacterial cell walls.
    Eur J Clin Microbiol. 1986 Dec;5(6):682-4 PMID: 3100293
  265. Generation of purpura-producing principle from pneumococcal cell walls.
    J Bacteriol. 1985 Jul;163(1):389-91 PMID: 4008446
  266. Evolution of the subclass of IgG antibody to type 3 pneumococcal polysaccharide during childhood.
    Clin Exp Immunol. 1987 Nov;70(2):449-55 PMID: 3427829
  267. The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media.
    J Infect Dis. 1988 Feb;157(2):245-55 PMID: 3335809
  268. The influence of fever on the development of experimental Streptococcus pneumoniae meningitis.
    J Infect Dis. 1987 Nov;156(5):849-50 PMID: 3655405
  269. The clinical effectiveness of pneumococcal vaccine in the elderly.
    Ann Intern Med. 1988 May;108(5):653-7 PMID: 3358567
  270. Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.
    Infect Immun. 1983 Jan;39(1):233-8 PMID: 6600444
  271. Lectin mediated adhesion of Streptococcus pneumoniae and its specific inhibition in vitro and in vivo.
    Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Jun;265(1-2):160-8 PMID: 3673330
  272. Lyase activity of inducible S8-depolymerases from Bacillus palustris.
    Biochim Biophys Acta. 1966 Jun 29;121(2):343-8 PMID: 5962521
  273. Agglutination and phagocytosis of pneumococci by immunoglobulin G antibodies of restricted heterogeneity.
    J Lab Clin Med. 1983 Jun;101(6):847-56 PMID: 6854124
  274. Combined IgG2, IgG4 and IgA deficiency: low C1q concentrations and the presence of excess C1r and C1s in an adult patient with recurrent pneumococcal infections.
    Acta Pathol Microbiol Immunol Scand C. 1985 Dec;93(6):257-63 PMID: 2424262
  275. Leads from the MMWR. Recommendations of the Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine.
    JAMA. 1989 Mar 3;261(9):1265-7 PMID: 2644464
  276. A new pneumococcus type. Type 47 A.
    Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(4):497-500 PMID: 4118732
  277. Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascitic fluid of cirrhotic patients.
    J Clin Microbiol. 1983 Jul;18(1):154-9 PMID: 6885986
  278. The structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 11F (American type 11).
    Can J Biochem Cell Biol. 1985 Sep;63(9):953-68 PMID: 4075231
  279. The role of complement in inflammation during experimental pneumococcal meningitis.
    Microb Pathog. 1986 Feb;1(1):15-32 PMID: 3508483
  280. Pneumococcal vaccine and patients with chronic lung disease.
    Ann Intern Med. 1986 Jan;104(1):106-9 PMID: 3940477
  281. The structure of the Streptococcus pneumoniae type 29 polysaccharide: a re-examination.
    Carbohydr Res. 1988 Dec 31;184:288-91 PMID: 3242814
  282. Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus.
    Can J Biochem. 1980 Feb;58(2):112-20 PMID: 6155983
  283. Pneumococcal vaccine and otitis media in infancy.
    Bull Eur Physiopathol Respir. 1983 Mar-Apr;19(2):235-8 PMID: 6871501
  284. Pneumococcal vaccination: the response of patients with multiple myeloma.
    Am J Med. 1980 Sep;69(3):419-23 PMID: 7416188
  285. Biochemistry and Genetics of the ABO, Lewis, and P blood group systems.
    Adv Hum Genet. 1980;10:1-136, 379-85 PMID: 6156588
  286. Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia.
    Am J Dis Child. 1986 May;140(5):428-32 PMID: 3962935
  287. Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells.
    J Exp Med. 1983 Aug 1;158(2):559-70 PMID: 6886624
  288. Granulocyte phagocytosis and killing virulent and avirulent serotypes of Streptococcus pneumoniae.
    J Lab Clin Med. 1982 Aug;100(2):279-87 PMID: 6284848
  289. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.
    J Infect Dis. 1983 Dec;148(6):1136-59 PMID: 6361173
  290. Secretory immunity and the bacterial IgA proteases.
    Rev Infect Dis. 1981 May-Jun;3(3):521-34 PMID: 6792682
  291. T-cell antigenic sites tend to be amphipathic structures.
    Proc Natl Acad Sci U S A. 1985 Oct;82(20):7048-52 PMID: 2413457
  292. Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.
    CMAJ. 1987 Feb 15;136(4):361-5 PMID: 3545418
  293. Type 48, a new Pneumococcus type.
    Acta Pathol Microbiol Scand. 1962;56:87-8 PMID: 13931658
  294. Update: pneumococcal polysaccharide vaccine usage--United States. Recommendations of the Immunization Practices Advisory Committee.
    Ann Intern Med. 1984 Sep;101(3):348-50 PMID: 6465703
  295. Immunological adjuvants. Report of a WHO scientific group.
    World Health Organ Tech Rep Ser. 1976;(595):1-40 PMID: 824865
  296. Pneumococcal bacteraemia--a continuing challenge.
    Q J Med. 1984 Spring;53(210):259-70 PMID: 6463199
  297. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine.
    J Infect Dis. 1986 Oct;154(4):590-6 PMID: 3528315
  298. [Multicenter study of pneumococcal serotypes in Africa].
    Bull World Health Organ. 1983;61(4):661-9 PMID: 6605214
  299. Ultrastructural localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigen in pneumococci.
    Infect Immun. 1988 Aug;56(8):1890-6 PMID: 3397179
  300. Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A.
    Infect Immun. 1988 May;56(5):1076-83 PMID: 2965680
  301. Antigen detection in the diagnosis and in the prognostic assessment of bacterial pneumonias.
    Diagn Microbiol Infect Dis. 1986 Mar;4(3 Suppl):35S-46S PMID: 2938873
  302. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 2, a reinvestigation.
    Carbohydr Res. 1988 Oct 15;182(1):111-7 PMID: 3242800
  303. Isolation and structural studies of phosphate-containing oligosaccharides from alkaline and acid hydrolysates of Streptococcus pneumoniae type 6B capsular polysaccharide.
    Carbohydr Res. 1989 Apr 15;187(2):267-86 PMID: 2743350
  304. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components.
    Infect Immun. 1989 Jul;57(7):1890-3 PMID: 2786503
  305. Pneumococcal antibodies (IgG, IgM) in patients with chronic obstructive lung disease 3 years after pneumococcal vaccination.
    Med Microbiol Immunol. 1985;174(1):51-8 PMID: 4000066
  306. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    J Clin Invest. 1982 Jan;69(1):85-98 PMID: 7054244
  307. Characterization of the cellular immune response following in vivo immunization with pneumococcal polysaccharides in man.
    Bull Eur Physiopathol Respir. 1983 Mar-Apr;19(2):227-34 PMID: 6347283
  308. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men.
    JAMA. 1987 Apr 17;257(15):2047-50 PMID: 3560380
  309. A new pneumococcus type. Type 12A.
    Acta Pathol Microbiol Scand. 1967;70(2):305-10 PMID: 4383090
  310. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro.
    Infect Immun. 1989 Jul;57(7):2006-13 PMID: 2731981
  311. Immunochemistry of pneumococcal types II, V, and VI. IV. Cross-reactions of type V antipneumococcal sera and their bearing on the relation between types II and V.
    Arch Biochem Biophys. 1962 Sep;Suppl 1:169-73 PMID: 13953334
  312. Monoclonal idiotope vaccine against Streptococcus pneumoniae infection.
    Science. 1984 Dec 14;226(4680):1325-6 PMID: 6505692
  313. Pneumococcal antibodies in families with recurrent otitis media.
    Int Arch Allergy Appl Immunol. 1984;75(2):139-42 PMID: 6469385
  314. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants.
    Pediatr Infect Dis. 1986 Jan-Feb;5(1):45-50 PMID: 3945575
  315. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides.
    Clin Immunol Immunopathol. 1987 Jul;44(1):114-21 PMID: 3297436
  316. Attachment of pneumococcal autolysin to wall teichoic acids, an essential step in enzymatic wall degradation.
    J Bacteriol. 1984 Jun;158(3):1188-90 PMID: 6144667
  317. Prophylaxis and treatment of pneumococcal bacteremia by immune globulin intravenous in a mouse model.
    Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 1):62-71 PMID: 2491979
  318. C-reactive protein is protective against Streptococcus pneumoniae infection in mice.
    J Exp Med. 1981 Nov 1;154(5):1703-8 PMID: 7299351
  319. Characterization and activity of contrasuppressor T cells induced by type III pneumococcal polysaccharide.
    J Immunol. 1986 Nov 1;137(9):2761-7 PMID: 2944962
  320. Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies.
    Microb Pathog. 1986 Dec;1(6):519-31 PMID: 3508498
  321. Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6.
    Infect Immun. 1982 Sep;37(3):987-92 PMID: 7129640
  322. Early pulmonary granulocyte recruitment in response to Streptococcus pneumoniae.
    Am Rev Respir Dis. 1984 Jan;129(1):87-91 PMID: 6703489
  323. Streptococcus pneumoniae type 16A, a hitherto undescribed pneumococcal type.
    J Clin Microbiol. 1985 Jul;22(1):127-8 PMID: 4019736
  324. The Forssman antigen of pneumococcus.
    Jpn J Exp Med. 1967 Dec;37(6):581-92 PMID: 4387139
  325. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.
    Infect Immun. 1984 Sep;45(3):582-91 PMID: 6332076
  326. Immunological self, nonself discrimination.
    Science. 1987 Feb 20;235(4791):865-70 PMID: 2433769
  327. Altered peptidoglycan structure in a pneumococcal transformant resistant to penicillin.
    J Bacteriol. 1988 May;170(5):2143-7 PMID: 3360741
  328. Persistence of antibodies to pneumococcal vaccine in patients with chronic renal failure.
    Kidney Int. 1985 Oct;28(4):672-7 PMID: 3910915
  329. Pneumococcal polysaccharide vaccines.
    Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S598-602 PMID: 2669103
  330. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era.
    Arch Intern Med. 1974 Sep;134(3):505-10 PMID: 4152800
  331. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.
    Infect Immun. 1989 May;57(5):1457-64 PMID: 2707854
  332. THE PROTECTIVE ACTION OF A SPECIFIC ENZYME AGAINST TYPE III PNEUMOCOCCUS INFECTION IN MICE.
    J Exp Med. 1931 Jun 30;54(1):73-89 PMID: 19869903
  333. Nature of the cross-protective antigen in subcellular vaccines of Streptococcus pneumoniae.
    Infect Immun. 1981 Jan;31(1):160-8 PMID: 7216442
  334. The fixation of C3b to pneumococcal cell wall polymers as a result of activation of the alternative complement pathway.
    J Immunol. 1981 Oct;127(4):1287-9 PMID: 7024404
  335. Quantitative studies of the specificity of anti-pneumococcal antibodies, types 3 and 8. IV. Binding of labeled hexasaccharides derived from S3 by anti-S3 antibodies and their Fab fragments.
    J Immunol. 1969 Sep;103(3):491-5 PMID: 4185041
  336. Horse anti-type XIV Pneumococcus sera behave as cold agglutinins recognizing developmentally regulated antigens apart from the Ii antigens on human erythrocytes.
    Vox Sang. 1982 Nov;43(5):253-8 PMID: 7147858
  337. Immunochemical studies on blood groups--LXVIII. The combining site of anti-I Ma (group 1).
    Immunochemistry. 1978 Nov;15(10-11):727-31 PMID: 85598
  338. Streptococcus pneumoniae type XIV polysaccharide: synthesis of a repeating branched tetrasaccharide with dioxa-type spacer-arms.
    Carbohydr Res. 1986 Aug 1;150:199-212 PMID: 3756957
  339. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 12A.
    Carbohydr Res. 1983 Apr 1;114(2):257-66 PMID: 6850674
  340. Recurrent pneumococcal sepsis and defective opsonization after pneumococcal capsular polysaccharide vaccine in a child with nephrotic syndrome.
    J Pediatr. 1980 May;96(5):882-5 PMID: 7365596
  341. Distribution of kappa and lambda light chain isotypes among human blood immunoglobulin-secreting cells after vaccination with pneumococcal polysaccharides.
    Scand J Immunol. 1989 Feb;29(2):159-64 PMID: 2493676
  342. Immunochemistry of pneumococcal types II, V, and VI. II. Inhibition tests in the type VI precipitating system.
    J Bacteriol. 1961 Dec;82:920-6 PMID: 14490831
  343. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    J Immunol. 1983 Jul;131(1):409-15 PMID: 6223077
  344. Blood clearance of Streptococcus pneumoniae by C-reactive protein.
    J Immunol. 1987 Apr 15;138(8):2598-603 PMID: 3559209
  345. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
    Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S184-97 PMID: 7025158
  346. Evaluation of the role of the pneumococcal Forssman antigen (F-polysaccharide) in the cross-serotype protection induced by pneumococcal subcellular preparations.
    Infect Immun. 1981 Jan;31(1):169-73 PMID: 7216443
  347. Pneumococcal vaccination: the response of patients with alcoholic liver cirrhosis.
    Hepatology. 1984 Sep-Oct;4(5):946-9 PMID: 6479858
  348. Immunochemical characterization of native polysaccharides from group B streptococcus: the relationship of the type III and group B determinants.
    J Immunol. 1978 Sep;121(3):1096-105 PMID: 80423
  349. Structural studies of the Klebsiella type 9 capsular polysaccharide.
    Carbohydr Res. 1972 Nov;25(1):49-57 PMID: 4679717
  350. Influence of multiple genes on the magnitude of the antibody response to bacterial polysaccharide antigens.
    Infect Immun. 1984 Jul;45(1):56-61 PMID: 6429050
  351. Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination.
    Eur J Clin Microbiol. 1983 Oct;2(5):453-8 PMID: 6641723
  352. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.
    Infect Immun. 1983 Jan;39(1):403-9 PMID: 6822421
  353. The structures of the cross-reactive types 19 (19F) and 57 (19A) pneumococcal capsular polysaccharides.
    J Biol Chem. 1980 Jul 25;255(14):6847-53 PMID: 6771279
  354. Bacterial factors chemotactic for polymorphonuclear leukocytes.
    Am J Pathol. 1968 Apr;52(4):725-36 PMID: 4384494
  355. Vaccination-induced activation of human blood T cells suppressing pneumococcal polysaccharide-specific B cells.
    Acta Pathol Microbiol Immunol Scand C. 1987 Apr;95(2):65-9 PMID: 3037850
  356. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides.
    J Clin Invest. 1983 Apr;71(4):1032-40 PMID: 6339558
  357. Characteristics of amplifier T cells involved in the antibody response to the capsular polysaccharide of type III Streptococcus pneumoniae.
    J Immunol. 1984 Jun;132(6):3103-8 PMID: 6202773
  358. Primary murine immunoglobulin M responses to certain pneumococcal capsular polysaccharides consist primarily of anti-pneumococcal cell wall carbohydrate antibodies.
    Infect Immun. 1986 Jun;52(3):867-71 PMID: 3710589
  359. Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes.
    J Exp Med. 1983 May 1;157(5):1692-7 PMID: 6189946
  360. Host mechanisms which act to remove bacteria from the blood stream.
    Bacteriol Rev. 1960 Mar;24(1):50-66 PMID: 14438353
  361. Genetic and nongenetic control of the immune response of mice to a synthetic glycolipid, stearylisomaltotetraose.
    Cell Immunol. 1985 Apr 15;92(1):172-83 PMID: 3935333
  362. Structural analysis of the specific capsular polysaccharide of Streptococcus pneumoniae type 45 (American type 72).
    Biochemistry. 1988 Sep 6;27(18):6820-9 PMID: 3196684
  363. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Infect Immun. 1981 Jan;31(1):228-35 PMID: 7216447
  364. Pneumococcal serotypes causing bacteremia and meningitis: relevance to composition of pneumococcal vaccine.
    Can Med Assoc J. 1981 Aug 1;125(3):263-7 PMID: 7272879
  365. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.
    N Engl J Med. 1987 Jul 2;317(1):18-22 PMID: 3587309
  366. Specific immunoglobulin-class antibody responses in the elderly before and after 14-valent pneumococcal vaccine.
    J Infect Dis. 1985 May;151(5):845-9 PMID: 3989318
  367. Studies on immunological paralysis. V. The influence of molecular weight on the immunogenicity, tolerogenicity and antibody-neutralizing activity of the 3 pneumococcal polysaccharide.
    Immunology. 1971 Sep;21(3):535-46 PMID: 4398137
  368. Activation of the alternative complement pathway by pneumococcal lipoteichoic acid.
    Infect Immun. 1985 Feb;47(2):384-7 PMID: 3881346
  369. Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjögren's syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4.
    N Engl J Med. 1985 Apr 18;312(16):1039-42 PMID: 3982455
  370. Non-antibody-containing fractions of breast milk inhibit epithelial attachment of Streptococcus pneumoniae and Haemophilus influenzae.
    Lancet. 1985 Mar 16;1(8429):643 PMID: 2857983
  371. Risk factors for acquiring pneumococcal infections.
    Arch Intern Med. 1986 Nov;146(11):2179-85 PMID: 3778047
  372. The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae.
    Am Rev Respir Dis. 1984 Jan;129(1):82-6 PMID: 6703488
  373. Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.
    Lancet. 1979 Jan;1(8107):75-7 PMID: 84130
  374. Chemical structure of and immune response to polysaccharides of Streptococcus pneumoniae.
    Rev Infect Dis. 1981 Mar-Apr;3(2):323-31 PMID: 7020047
  375. IgG subclasses of pneumococcal antibodies--effect of allotype G2m(n).
    Scand J Immunol. 1989 Feb;29(2):229-37 PMID: 2922573
  376. Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.
    J Immunol. 1974 Jun;112(6):2020-7 PMID: 4151107
  377. Immunologic responses of children to serious infections with Streptococcus pneumoniae.
    J Infect Dis. 1983 Sep;148(3):427-35 PMID: 6619573
  378. Antibody activity before and after pneumococcal vaccination of otitis-prone and non-otitis-prone children.
    Acta Otolaryngol. 1986 May-Jun;101(5-6):467-74 PMID: 3727981
  379. Role of the liver in host defense to pneumococcus following splenectomy.
    J Surg Res. 1984 Dec;37(6):448-52 PMID: 6513540
  380. Antigen requirements for priming of type III pneumococcal polysaccharide-specific IgG memory responses: suppression of memory with the T-independent form of antigen.
    Cell Immunol. 1981 Oct;64(1):177-86 PMID: 6170457
  381. Structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 23F (American type 23).
    Biochem Cell Biol. 1988 Jul;66(7):758-71 PMID: 2846013
  382. Pneumococcal type-associated variability in alternate complement pathway activation.
    Infect Immun. 1975 Oct;12(4):772-8 PMID: 329
  383. Structure of the peptide network of pneumococcal peptidoglycan.
    J Biol Chem. 1987 Nov 15;262(32):15400-5 PMID: 2890629
  384. A protective human monoclonal IgA antibody produced in vitro: anti-pneumococcal antibody engendered by Epstein-Barr virus-immortalized cell line.
    Eur J Immunol. 1986 Feb;16(2):187-93 PMID: 3007166
  385. Extracellular killing of inhaled pneumococci in rats.
    J Lab Clin Med. 1987 Dec;110(6):753-66 PMID: 3681117
  386. Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls.
    Infect Immun. 1981 Oct;34(1):20-5 PMID: 7028628
  387. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.
    J Exp Med. 1981 Mar 1;153(3):694-705 PMID: 7252411
  388. Type variation of strains of Streptococcus pneumoniae in capsular serogroup 15.
    J Infect Dis. 1983 Jun;147(6):1041-54 PMID: 6854063
Article Info
Journal
Antonie van Leeuwenhoek
Abbr.
Antonie Van Leeuwenhoek
ISSN
0003-6072
DOI
10.1007/BF02388078
Published
1990-06-00
Pages
1-47
Language
English
Region
Netherlands
NLM ID
0372625
Subset
IM
External Links
PubMed source DOI: 10.1007/BF02388078 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2